Designing Better Pediatric Medicines: Strategies to meet patient needs and regulatory expectations in the development of acceptable age-appropriate dosage forms

London, United Kingdom | 18 March 2026
Overview

Join us for a full-day event dedicated to advancing pediatric medicine, featuring expert-led sessions and networking opportunities. 

Hosted by the Quotient Sciences team, this event brings together leading professionals to discuss key topics in pediatric drug development, including taste and palatability assessments, regulatory considerations, food compatibility, formulation development, and patient acceptability.

The agenda includes presentations from renowned speakers, interactive Q&A sessions, and ample time for networking over lunch and a drinks reception. Whether you’re looking to deepen your expertise, connect with peers, or explore the latest innovations in pediatric science, this event promises valuable insights and engaging discussions.

  • Key learning objectives
  • Taste and palatability assessment approaches for pediatric dosage forms
  • Regulatory perspectives on PIP/PSP, pediatric QTPP, and excipient risk assessment  
  • Pediatric biopharmaceutics considerations  
  • Food compatibility in pediatric studies
  • Formulation development pathways for pediatric products
  • Patientcentric design and acceptability in hospital settings  
Time/Date 

Duration: 09:00 AM – 5:00 PM 

Wednesday, March 18th 2026

09:00 AM – 09:15 AM - Welcome & Introduction - Nazim Kanji, Quotient Sciences

09:15 AM – 10:00 AM - Catherine Tuleu, UCL 

Topic: 

Taste/Palatability Assessments Q&A   

10:00 AM – 10:45 AM - Jenny Walsh, Jenny Walsh Consulting

Topics:  

Regulatory – PIP/PSP

Pediatric QTPP

Excipient Risk Assessment

Q&A  

10:45 AM – 11:00 AM - Coffee Break 

11:00 AM – 11:45 AM - Hannah Batchelor, Strathclyde University

Topic: 

Pediatric Biopharmaceutics

Q&A  

11:45 AM – 12.30 PM - Kingsley Iyoha, Quotient Sciences

Topic: Pediatric Formulation Development

Q&A  

12:30 PM – 13:15 PM - Justin Holland, Quotient Sciences

Topic: 

Food Compatibility

Q&A  

13.15 PM – 2:00 PM - Lunch & Networking

2:00 PM – 2:45 PM - TBC

Topic: Flavour Masking of Pediatric Formulations

2:45 PM– 3.30 PM - Louise Bracken, Alder Hey Children’s Hospital

Topics:  

Patient Considerations for Pediatric Dosage Form Design (TBC)

Pediatric Acceptability

3.30 PM– 5:00 PM - Drinks reception - Closing Remarks - Nazim Kanji, Quotient Sciences

Open floor for questions

 

Register
Location
Royal Society of Chemistry or Royal Pharmaceutical Society
Burlington House, Piccadilly, W1J 0BA
London, United Kingdom

Meet our experts:

We look forward to meeting you at the seminar.

Nazim Kanji

Executive Director, Pediatric Services

Nazim Kanji has over 25 years of experience in the pharmaceutical and consumer healthcare industries, where he has worked in produ...

About Nazim
Dr. Catherine Tuleu

Professor of Paediatric Pharmaceutics

Dr. Catherine Tuleu is a UK-qualified French pharmacist. She graduated from Université Paris V and obtained her PhD with distincti...

About Catherine
Jenny Walsh

Pharmaceutical Development Consultant and Director at Jenny Walsh Consulting Ltd

Jenny is a highly motivated and proactive PhD pharmacist with over 25 years experience in pharmaceutical and consumer product rese...

About Jenny
Hannah Batchelor

Strathclyde Institute of Pharmacy and Biomedical Sciences Director of Research

About Hannah
Kingsley Iyoha

Senior Director, Development, Formulation Development

Kingsley has expertise and applied skills coming from a grounding in the pharmaceutical, consumer health & personal care indus...

About Kingsley
Justin Holland

Executive Director, UK Analytical, Analytical Development

About Justin
Louise Bracken

Co-Director Paediatric Medicines Research Unit and Senior Research Pharmacist at Alder Hey Children's NHS Foundation Trust

About Louise

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Learn more
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Learn more
Translational Pharmaceutics, Formulation Development, Peptides, Dr. Andrew Lewis Using a formulation design space with Translational Pharmaceutics® for success in oral peptide development
Learn more